Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. MANUFACTURING SERVICES AGREEMENTManufacturing Services Agreement • May 31st, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT WITNESSES THAT in consideration of the rights conferred and the obligations assumed herein, and for other good and valuable consideration (the receipt and sufficiency of which are acknowledged by each party), and intending to be legally bound the parties agree as follows:
EXECUTION COPY Commercial Supply Agreement – JUNE 2011 1Commercial Supply Agreement • May 31st, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • Delaware
SETTLEMENT & AMENDMENT CONCERNING A MANUFACTURING AGREEMENT DATED DECEMBER 2, DATED JUNE 20, 2011Settlement & Amendment Concerning a Manufacturing Agreement and a Commercial Supply Agreement • May 31st, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • Delaware
Confidential Materials omitted and filed separately with the Securities and Exchange Commission. Double asterisks denote omissions. SUPPLY AGREEMENT Between CNJ Holdings Inc. and Rovi Contract Manufacturing, S.L.Supply Agreement • May 31st, 2016 • Aptevo Therapeutics Inc. • Pharmaceutical preparations • England
This Supply Agreement, effective as of April 29th, 2014 (the “Effective Date”), is entered by and between CNJ Holdings Inc., doing business as Emergent BioSolutions, with an address at c/o 155 Innovation Drive, Winnipeg, Manitoba, Canada R3T 5Y3 (“Cangene”), and Rovi Contract Manufacturing, S.L., with an address at Julian Camarillo, 35, 28037 Madrid, SPAIN (“Company”).
